Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomized Trial of Regional Versus Systemic Continuous Gemcitabine Chemotherapy in the Treatment of Unresectable Pancreatic Cancer

NCT01665625 is registered in ClinicalTrials.gov with Air Force Military Medical University, China as lead sponsor.

NCT NCT01665625
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01665625 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomized Trial of Regional Versus Systemic Continuous Gemcitabine Chemotherapy in the Treatment of Unresectable Pancreatic Cancer
Lead sponsor
Air Force Military Medical University, China
Phase
Not applicable
Overall status
Unknown status
Start date
August 31, 2012
Completion date
February 29, 2016
Enrollment
90 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

unresectable pancreatic cancer